Catherine Scott-Wilson

533 total citations
9 papers, 266 citations indexed

About

Catherine Scott-Wilson is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Catherine Scott-Wilson has authored 9 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Physiology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Catherine Scott-Wilson's work include Asthma and respiratory diseases (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Respiratory Support and Mechanisms (4 papers). Catherine Scott-Wilson is often cited by papers focused on Asthma and respiratory diseases (7 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (7 papers) and Respiratory Support and Mechanisms (4 papers). Catherine Scott-Wilson collaborates with scholars based in United States, United Kingdom and Spain. Catherine Scott-Wilson's co-authors include Courtney Crim, Lisa Sanford, Fernando J. Martínez, Sally Kilbride, Peter M.A. Calverley, Gregory Feldman, Joseph Boscia, Leonardo M. Fabbri, Àlvar Agustí and Edward Kerwin and has published in prestigious journals such as BMJ Open, Clinical Therapeutics and Respiratory Medicine.

In The Last Decade

Catherine Scott-Wilson

8 papers receiving 261 citations

Peers

Catherine Scott-Wilson
Leonard Dunn United States
Donna Reilly United States
Kenneth Chinsky United States
Paul Hergenroeder United States
Anna Selby United Kingdom
Xavier Nuñez Switzerland
Enson Thomas United Kingdom
Patrice Popelková Czechia
Anna Whalen-Browne Canada
Silke Geier Germany
Leonard Dunn United States
Catherine Scott-Wilson
Citations per year, relative to Catherine Scott-Wilson Catherine Scott-Wilson (= 1×) peers Leonard Dunn

Countries citing papers authored by Catherine Scott-Wilson

Since Specialization
Citations

This map shows the geographic impact of Catherine Scott-Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Scott-Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Scott-Wilson more than expected).

Fields of papers citing papers by Catherine Scott-Wilson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Scott-Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Scott-Wilson. The network helps show where Catherine Scott-Wilson may publish in the future.

Co-authorship network of co-authors of Catherine Scott-Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Scott-Wilson. A scholar is included among the top collaborators of Catherine Scott-Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Scott-Wilson. Catherine Scott-Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Horne, Benjamin D., Dawn Midwinter, Catherine Scott-Wilson, et al.. (2021). Validation of the Summit Lab Score in Predicting Exacerbations of Chronic Obstructive Pulmonary Disease Among Individuals with High Arterial Stiffness. International Journal of COPD. Volume 16. 41–51.
2.
Bhatt, Surya P., John Cockcroft, Jie Wang‐Jairaj, et al.. (2017). A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD. International Journal of COPD. Volume 12. 351–365. 15 indexed citations
3.
Siler, Thomas M., Atsushi Nagai, Catherine Scott-Wilson, Dawn Midwinter, & Courtney Crim. (2016). A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 μg versus once-daily vilanterol 25 μg to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD. Respiratory Medicine. 123. 8–17. 18 indexed citations
4.
Covelli, Henry D., Bonavuth Pek, Isabelle Schenkenberger, et al.. (2015). Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk. International Journal of COPD. 11. 1–1. 21 indexed citations
5.
Kerwin, Edward, Catherine Scott-Wilson, Lisa Sanford, et al.. (2013). A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD. Respiratory Medicine. 107(4). 560–569. 73 indexed citations
6.
Martínez, Fernando J., Joseph Boscia, Gregory Feldman, et al.. (2013). Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: A randomised trial. Respiratory Medicine. 107(4). 550–559. 90 indexed citations
7.
Lötvall, Jan, Leif Bjermer, Sigurd Steinshamn, et al.. (2012). Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial. BMJ Open. 2(1). e000370–e000370. 37 indexed citations
8.
Edin, Heather M., et al.. (2009). Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life. Annals of Allergy Asthma & Immunology. 102(4). 323–327. 3 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonard Dunn Breakdown of academic impact, for papers by Donna Reilly Breakdown of academic impact, for papers by Kenneth Chinsky Breakdown of academic impact, for papers by Paul Hergenroeder Breakdown of academic impact, for papers by Anna Selby Breakdown of academic impact, for papers by Xavier Nuñez Breakdown of academic impact, for papers by Enson Thomas Breakdown of academic impact, for papers by Patrice Popelková Breakdown of academic impact, for papers by Anna Whalen-Browne Breakdown of academic impact, for papers by Silke Geier
Rankless by CCL
2026